A Single and Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics SCH 900931 in Healthy Adult Japanese Subjects.
Not yet recruiting
- Conditions
- Healthy volunteersOther - Research that is not of generic health relevance and not applicable to specific health categories listed above
- Registration Number
- ACTRN12611000568910
- Lead Sponsor
- Schering-Plough Research Institute, a Division of Schering Corporation, a Subsidiary of Merck & Co., Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Healthy Japanese volunteers
Exclusion Criteria
History of malignancy, Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method